Trials / Not Yet Recruiting

Not Yet RecruitingNCT06763692

Low Intensity Focused Ultrasound for Parkinson's Disease

Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Parkinson's Disease

Status: Not Yet Recruiting
Phase: N/A
Study type: Interventional
Enrollment: 15 (estimated)

Sponsor: Ali Rezai · Academic / Other
Sex: All
Age: 45 Years – 80 Years
Healthy volunteers: Not accepted

Summary

This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with parkinson's Disease

Detailed description

The primary objective is to evaluate the safety, feasibility and tolerability of LIFU as an adjunct neuromodulatory treatment for Parkinson's Disease

Conditions

Parkinson Disease

Interventions

Type	Name	Description
DEVICE	LIFU Neuromodulation	Subjects will undergo a single LIFU of the target brain region

Timeline

Start date: 2026-12-01
Primary completion: 2027-03-30
Completion: 2028-03-30
First posted: 2025-01-08
Last updated: 2026-02-17

Regulatory

FDA-regulated device study

Source: ClinicalTrials.gov record NCT06763692. Inclusion in this directory is not an endorsement.